{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:22:56Z","timestamp":1779909776603,"version":"3.53.1"},"reference-count":114,"publisher":"Bentham Science Publishers Ltd.","issue":"15","funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Provincial","doi-asserted-by":"publisher","award":["2020JJ4552"],"award-info":[{"award-number":["2020JJ4552"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Ferroptosis is a newly discovered form of programmed cell death characterized by\niron overload, ROS accumulation, and lipid peroxidation. It is distinguished by unique morphological, biochemical, and genetic features and stands apart from other known regulated cell\ndeath mechanisms. Studies have demonstrated a close association between ferroptosis and various cancers, including liver cancer, lung cancer, renal cell carcinoma, colorectal cancer, pancreatic cancer, and ovarian cancer. Inducing ferroptosis has shown promising results in inhibiting\ntumor growth and reversing tumor progression. However, the challenge lies in regulating ferroptosis in vivo due to the scarcity of potent compounds that can activate it. Integrating emerging\nbiomedical discoveries and technological innovations with conventional therapies is imperative.\nNotably, considerable progress has been made in cancer treatment by leveraging immunotherapy\nand nanotechnology to trigger ferroptosis. This review explores the relationship between ferroptosis and emerging immunotherapies and nanotechnologies, along with their potential underlying mechanisms, offering valuable insights for developing novel cancer treatment strategies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010276664231228124157","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T10:16:43Z","timestamp":1706523403000},"page":"2012-2021","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer:\nFocus on Immunotherapy and Nanotechnology"],"prefix":"10.2174","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3590-4341","authenticated-orcid":true,"given":"Zongchao","family":"Yu","sequence":"first","affiliation":[{"name":"Department of General Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China,\nHengyang, Hunan, 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongcheng","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, 541199, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China,\nHengyang, Hunan, 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengzhe","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China,\nHengyang, Hunan, 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, 541199, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China,\nHengyang, Hunan, 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","volume":"35","author":"Vinay D.S.","year":"2015","unstructured":"Vinay D.S.; Ryan E.P.; Pawelec G.; Talib W.H.; Stagg J.; Elkord E.; Lichtor T.; Decker W.K.; Whelan R.L.; Kumara H.; Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol  2015,35,S185-S198","journal-title":"Semin Cancer Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","volume":"48","author":"Wellenstein M.D.","year":"2018","unstructured":"Wellenstein M.D.; de Visser K.E.; Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape. Immunity  2018,48(3),399-416","journal-title":"Immunity"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00535-020-01666-y","volume":"55","author":"Okusaka T.","year":"2020","unstructured":"Okusaka T.; Furuse J.; Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines. J Gastroenterol  2020,55(4),369-382","journal-title":"J Gastroenterol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.6004\/jnccn.2013.0056","volume":"11","author":"Pugh T.J.","year":"2013","unstructured":"Pugh T.J.; Nguyen B.N.; Kanke J.E.; Johnson J.L.; Hoffman K.E.; Radiation therapy modalities in prostate cancer. J Natl Compr Canc Netw  2013,11(4),414-421","journal-title":"J Natl Compr Canc Netw"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-020-0113-2","volume":"5","author":"Wang L.","year":"2020","unstructured":"Wang L.; Qin W.; Huo Y.J.; Li X.; Shi Q.; Rasko J.E.J.; Janin A.; Zhao W.L.; Advances in targeted therapy for malignant lymphoma. Signal Transduct Target Ther  2020,5(1),15","journal-title":"Signal Transduct Target Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"27428","DOI":"10.18632\/oncotarget.16194","volume":"8","author":"Tang Z.","year":"2017","unstructured":"Tang Z.; Zeng Q.; Li Y.; Zhang X.; Ma J.; Suto M.J.; Xu B.; Yi N.; Development of a radiosensitivity gene signature for patients with soft tissue sarcoma. Oncotarget  2017,8(16),27428-27439","journal-title":"Oncotarget"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00120-021-01569-7","volume":"60","author":"Zraik I.M.","year":"2021","unstructured":"Zraik I.M.; He\u00df-Busch Y.; Management of chemotherapy side effects and their long-term sequelae. Urologe A  2021,60(7),862-871","journal-title":"Urologe A"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/BST20191055","volume":"48","author":"Lev S.","year":"2020","unstructured":"Lev S.; Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochem Soc Trans  2020,48(2),657-665","journal-title":"Biochem Soc Trans"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"Dixon S.J.","year":"2012","unstructured":"Dixon S.J.; Lemberg K.M.; Lamprecht M.R.; Skouta R.; Zaitsev E.M.; Gleason C.E.; Patel D.N.; Bauer A.J.; Cantley A.M.; Yang W.S.; Morrison B.; Stockwell B.R.; Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell  2012,149(5),1060-1072","journal-title":"Cell"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"Dolma S.","year":"2003","unstructured":"Dolma S.; Lessnick S.L.; Hahn W.C.; Stockwell B.R.; Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell  2003,3(3),285-296","journal-title":"Cancer Cell"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"Yang W.S.","year":"2008","unstructured":"Yang W.S.; Stockwell B.R.; Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol  2008,15(3),234-245","journal-title":"Chem Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"Yu H.","year":"2017","unstructured":"Yu H.; Guo P.; Xie X.; Wang Y.; Chen G.; Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med  2017,21(4),648-657","journal-title":"J Cell Mol Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.ijbiomac.2019.05.221","volume":"135","author":"Djulbegovic M.B.","year":"2019","unstructured":"Djulbegovic M.B.; Uversky V.N.; Ferroptosis \u2013 An iron- and disorder-dependent programmed cell death. Int J Biol Macromol  2019,135,1052-1069","journal-title":"Int J Biol Macromol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nrc2663","volume":"9","author":"Cotter T.G.","year":"2009","unstructured":"Cotter T.G.; Apoptosis and cancer: The genesis of a research field. Nat Rev Cancer  2009,9(7),501-507","journal-title":"Nat Rev Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"Czabotar P.E.","year":"2014","unstructured":"Czabotar P.E.; Lessene G.; Strasser A.; Adams J.M.; Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol  2014,15(1),49-63","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.tcb.2016.07.002","volume":"26","author":"Luna-Vargas M.P.A.","year":"2016","unstructured":"Luna-Vargas M.P.A.; Chipuk J.E.; Physiological and pharmacological control of BAK, BAX, and beyond. Trends Cell Biol  2016,26(12),906-917","journal-title":"Trends Cell Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"Murphy J.M.","year":"2013","unstructured":"Murphy J.M.; Czabotar P.E.; Hildebrand J.M.; Lucet I.S.; Zhang J.G.; Alvarez-Diaz S.; Lewis R.; Lalaoui N.; Metcalf D.; Webb A.I.; Young S.N.; Varghese L.N.; Tannahill G.M.; Hatchell E.C.; Majewski I.J.; Okamoto T.; Dobson R.C.J.; Hilton D.J.; Babon J.J.; Nicola N.A.; Strasser A.; Silke J.; Alexander W.S.; The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity  2013,39(3),443-453","journal-title":"Immunity"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-genet-071719-022748","volume":"55","author":"Xu D.","year":"2021","unstructured":"Xu D.; Zou C.; Yuan J.; Genetic regulation of RIPK1 and necroptosis. Annu Rev Genet  2021,55(1),235-263","journal-title":"Annu Rev Genet"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2022.07.007","volume":"86","author":"Zhang T.","year":"2022","unstructured":"Zhang T.; Wang Y.; Inuzuka H.; Wei W.; Necroptosis pathways in tumorigenesis. Semin Cancer Biol  2022,86(Pt 3),32-40","journal-title":"Semin Cancer Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imr.12287","volume":"265","author":"Jorgensen I.","year":"2015","unstructured":"Jorgensen I.; Miao E.A.; Pyroptotic cell death defends against intracellular pathogens. Immunol Rev  2015,265(1),130-142","journal-title":"Immunol Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ni.1960","volume":"11","author":"Miao E.A.","year":"2010","unstructured":"Miao E.A.; Leaf I.A.; Treuting P.M.; Mao D.P.; Dors M.; Sarkar A.; Warren S.E.; Wewers M.D.; Aderem A.; Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol  2010,11(12),1136-1142","journal-title":"Nat Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.15252\/embj.201796697","volume":"36","author":"Galluzzi L.","year":"2017","unstructured":"Galluzzi L.; Baehrecke E.H.; Ballabio A.; Boya P.; Bravo-San Pedro J.M.; Cecconi F.; Choi A.M.; Chu C.T.; Codogno P.; Colombo M.I.; Cuervo A.M.; Debnath J.; Deretic V.; Dikic I.; Eskelinen E.L.; Fimia G.M.; Fulda S.; Gewirtz D.A.; Green D.R.; Hansen M.; Harper J.W.; J\u00e4ttel\u00e4 M.; Johansen T.; Juhasz G.; Kimmelman A.C.; Kraft C.; Ktistakis N.T.; Kumar S.; Levine B.; Lopez-Otin C.; Madeo F.; Martens S.; Martinez J.; Melendez A.; Mizushima N.; M\u00fcnz C.; Murphy L.O.; Penninger J.M.; Piacentini M.; Reggiori F.; Rubinsztein D.C.; Ryan K.M.; Santambrogio L.; Scorrano L.; Simon A.K.; Simon H.U.; Simonsen A.; Tavernarakis N.; Tooze S.A.; Yoshimori T.; Yuan J.; Yue Z.; Zhong Q.; Kroemer G.; Molecular definitions of autophagy and related processes. EMBO J  2017,36(13),1811-1836","journal-title":"EMBO J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.semcancer.2013.05.008","volume":"23","author":"Pietrocola F.","year":"2013","unstructured":"Pietrocola F.; Izzo V.; Niso-Santano M.; Vacchelli E.; Galluzzi L.; Maiuri M.C.; Kroemer G.; Regulation of autophagy by stress-responsive transcription factors. Semin Cancer Biol  2013,23(5),310-322","journal-title":"Semin Cancer Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"151058","DOI":"10.1016\/j.ejcb.2019.151058","volume":"99","author":"Wang H.","year":"2020","unstructured":"Wang H.; Liu C.; Zhao Y.; Gao G.; Mitochondria regulation in ferroptosis. Eur J Cell Biol  2020,99(1),151058","journal-title":"Eur J Cell Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/humrep\/deaa363","volume":"36","author":"Li Y.","year":"2021","unstructured":"Li Y.; Zeng X.; Lu D.; Yin M.; Shan M.; Gao Y.; Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis. Hum Reprod  2021,36(4),951-964","journal-title":"Hum Reprod"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semcdb.2020.12.005","volume":"115","author":"Haschka D.","year":"2021","unstructured":"Haschka D.; Hoffmann A.; Weiss G.; Iron in immune cell function and host defense. Semin Cell Dev Biol  2021,115,27-36","journal-title":"Semin Cell Dev Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8810785","volume":"2020","author":"Zhu J.","year":"2020","unstructured":"Zhu J.; Xiong Y.; Zhang Y.; Wen J.; Cai N.; Cheng K.; Liang H.; Zhang W.; The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors. Oxid Med Cell Longev  2020,2020,1-14","journal-title":"Oxid Med Cell Longev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Xie Y.","year":"2016","unstructured":"Xie Y.; Hou W.; Song X.; Yu Y.; Huang J.; Sun X.; Kang R.; Tang D.; Ferroptosis: Process and function. Cell Death Differ  2016,23(3),369-379","journal-title":"Cell Death Differ"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.molcel.2023.03.005","volume":"83","author":"Dixon S.J.","year":"2023","unstructured":"Dixon S.J.; Pratt D.A.; Ferroptosis: A flexible constellation of related biochemical mechanisms. Mol Cell  2023,83(7),1030-1042","journal-title":"Mol Cell"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"Koppula P.","year":"2021","unstructured":"Koppula P.; Zhuang L.; Gan B.; Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell  2021,12(8),599-620","journal-title":"Protein Cell"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"Dixon S.J.","year":"2015","unstructured":"Dixon S.J.; Winter G.E.; Musavi L.S.; Lee E.D.; Snijder B.; Rebsamen M.; Superti-Furga G.; Stockwell B.R.; Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol  2015,10(7),1604-1609","journal-title":"ACS Chem Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"Friedmann Angeli J.P.","year":"2014","unstructured":"Friedmann Angeli J.P.; Schneider M.; Proneth B.; Tyurina Y.Y.; Tyurin V.A.; Hammond V.J.; Herbach N.; Aichler M.; Walch A.; Eggenhofer E.; Basavarajappa D.; R\u00e5dmark O.; Kobayashi S.; Seibt T.; Beck H.; Neff F.; Esposito I.; Wanke R.; F\u00f6rster H.; Yefremova O.; Heinrichmeyer M.; Bornkamm G.W.; Geissler E.K.; Thomas S.B.; Stockwell B.R.; O\u2019Donnell V.B.; Kagan V.E.; Schick J.A.; Conrad M.; Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol  2014,16(12),1180-1191","journal-title":"Nat Cell Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1038\/s41418-019-0299-4","volume":"26","author":"Li Y.","year":"2019","unstructured":"Li Y.; Feng D.; Wang Z.; Zhao Y.; Sun R.; Tian D.; Liu D.; Zhang F.; Ning S.; Yao J.; Tian X.; Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia\/reperfusion. Cell Death Differ  2019,26(11),2284-2299","journal-title":"Cell Death Differ"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e155724","DOI":"10.1172\/JCI155724","volume":"132","author":"Liu W.","year":"2022","unstructured":"Liu W.; \u00d6stberg N.; Yalcinkaya M.; Dou H.; Endo-Umeda K.; Tang Y.; Hou X.; Xiao T.; Fidler T.P.; Abramowicz S.; Yang Y.G.; Soehnlein O.; Tall A.R.; Wang N.; Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. J Clin Invest  2022,132(13),e155724","journal-title":"J Clin Invest"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"101716","DOI":"10.1016\/j.pneurobio.2019.101716","volume":"184","author":"Derry P.J.","year":"2020","unstructured":"Derry P.J.; Hegde M.L.; Jackson G.R.; Kayed R.; Tour J.M.; Tsai A.L.; Kent T.A.; Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer\u2019s disease from a ferroptosis perspective. Prog Neurobiol  2020,184,101716","journal-title":"Prog Neurobiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"Jiang X.","year":"2021","unstructured":"Jiang X.; Stockwell B.R.; Conrad M.; Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol  2021,22(4),266-282","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"Stockwell B.R.","year":"2020","unstructured":"Stockwell B.R.; Jiang X.; Gu W.; Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol  2020,30(6),478-490","journal-title":"Trends Cell Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"Yang W.S.","year":"2014","unstructured":"Yang W.S.; SriRamaratnam, R.; Welsch, M.E.; Shimada, K.; Skouta, R.; Viswanathan, V.S.; Cheah, J.H.; Clemons, P.A.; Shamji, A.F.; Clish, C.B.; Brown, L.M.; Girotti, A.W.; Cornish, V.W.; Schreiber, S.L.; Stockwell, B.R. Regulation of ferroptotic cancer cell death by GPX4. Cell  2014,156(1-2),317-331","journal-title":"Cell"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"Dixon S.J.","year":"2014","unstructured":"Dixon S.J.; Patel D.N.; Welsch M.; Skouta R.; Lee E.D.; Hayano M.; Thomas A.G.; Gleason C.E.; Tatonetti N.P.; Slusher B.S.; Stockwell B.R.; Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife  2014,3,e02523","journal-title":"eLife"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.freeradbiomed.2017.04.024","volume":"108","author":"Toyokuni S.","year":"2017","unstructured":"Toyokuni S.; Ito F.; Yamashita K.; Okazaki Y.; Akatsuka S.; Iron and thiol redox signaling in cancer: An exquisite balance to escape ferroptosis. Free Radic Biol Med  2017,108,610-626","journal-title":"Free Radic Biol Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2016.07.033","volume":"381","author":"Lin R.","year":"2016","unstructured":"Lin R.; Zhang Z.; Chen L.; Zhou Y.; Zou P.; Feng C.; Wang L.; Liang G.; Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. Cancer Lett  2016,381(1),165-175","journal-title":"Cancer Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.1021\/acs.jmedchem.8b01299","volume":"61","author":"Devisscher L.","year":"2018","unstructured":"Devisscher L.; Van Coillie S.; Hofmans S.; Van Rompaey D.; Goossens K.; Meul E.; Maes L.; De Winter H.; Van Der Veken P.; Vandenabeele P.; Berghe T.V.; Augustyns K.; Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy. J Med Chem  2018,61(22),10126-10140","journal-title":"J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2013.03.022","volume":"66","author":"Niki E.","year":"2014","unstructured":"Niki E.; Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med  2014,66,3-12","journal-title":"Free Radic Biol Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"Doll S.","year":"2017","unstructured":"Doll S.; Proneth B.; Tyurina Y.Y.; Panzilius E.; Kobayashi S.; Ingold I.; Irmler M.; Beckers J.; Aichler M.; Walch A.; Prokisch H.; Tr\u00fcmbach D.; Mao G.; Qu F.; Bayir H.; F\u00fcllekrug J.; Scheel C.H.; Wurst W.; Schick J.A.; Kagan V.E.; Angeli J.P.F.; Conrad M.; ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol  2017,13(1),91-98","journal-title":"Nat Chem Biol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.28159","volume":"133","author":"Louandre C.","year":"2013","unstructured":"Louandre C.; Ezzoukhry Z.; Godin C.; Barbare J.C.; Mazi\u00e8re J.C.; Chauffert B.; Galmiche A.; Iron\u2010dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer  2013,133(7),1732-1742","journal-title":"Int J Cancer"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/acschembio.9b00939","volume":"15","author":"Ye L.F.","year":"2020","unstructured":"Ye L.F.; Chaudhary K.R.; Zandkarimi F.; Harken A.D.; Kinslow C.J.; Upadhyayula P.S.; Dovas A.; Higgins D.M.; Tan H.; Zhang Y.; Buonanno M.; Wang T.J.C.; Hei T.K.; Bruce J.N.; Canoll P.D.; Cheng S.K.; Stockwell B.R.; Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol  2020,15(2),469-484","journal-title":"ACS Chem Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"042013","DOI":"10.1088\/1748-605X\/ac058a","volume":"16","author":"Li Y.","year":"2021","unstructured":"Li Y.; Wei X.; Tao F.; Deng C.; Lv C.; Chen C.; Cheng Y.; The potential application of nanomaterials for ferroptosis-based cancer therapy. Biomed Mater  2021,16(4),042013","journal-title":"Biomed Mater"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"Lang X.","year":"2019","unstructured":"Lang X.; Green M.D.; Wang W.; Yu J.; Choi J.E.; Jiang L.; Liao P.; Zhou J.; Zhang Q.; Dow A.; Saripalli A.L.; Kryczek I.; Wei S.; Szeliga W.; Vatan L.; Stone E.M.; Georgiou G.; Cieslik M.; Wahl D.R.; Morgan M.A.; Chinnaiyan A.M.; Lawrence T.S.; Zou W.; Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov  2019,9(12),1673-1685","journal-title":"Cancer Discov"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1039\/D0BM01168A","volume":"8","author":"Li Z.","year":"2020","unstructured":"Li Z.; Rong L.; Cascade reaction-mediated efficient ferroptosis synergizes with immunomodulation for high-performance cancer therapy. Biomater Sci  2020,8(22),6272-6285","journal-title":"Biomater Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"Hao X.","year":"2022","unstructured":"Hao X.; Zheng Z.; Liu H.; Zhang Y.; Kang J.; Kong X.; Rong D.; Sun G.; Sun G.; Liu L.; Yu H.; Tang W.; Wang X.; Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol  2022,56,102463","journal-title":"Redox Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"Liao P.","year":"2022","unstructured":"Liao P.; Wang W.; Wang W.; Kryczek I.; Li X.; Bian Y.; Sell A.; Wei S.; Grove S.; Johnson J.K.; Kennedy P.D.; Gij\u00f3n M.; Shah Y.M.; Zou W.; CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell  2022,40(4),365-378.e6","journal-title":"Cancer Cell"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"Wang W.","year":"2019","unstructured":"Wang W.; Green M.; Choi J.E.; Gij\u00f3n M.; Kennedy P.D.; Johnson J.K.; Liao P.; Lang X.; Kryczek I.; Sell A.; Xia H.; Zhou J.; Li G.; Li J.; Li W.; Wei S.; Vatan L.; Zhang H.; Szeliga W.; Gu W.; Liu R.; Lawrence T.S.; Lamb C.; Tanno Y.; Cieslik M.; Stone E.; Georgiou G.; Chan T.A.; Chinnaiyan A.; Zou W.; CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature  2019,569(7755),270-274","journal-title":"Nature"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"117113","DOI":"10.1016\/j.envres.2023.117113","volume":"238","author":"Tao C.","year":"2023","unstructured":"Tao C.; Rouhi J.; A biosensor based on graphene oxide nanocomposite for determination of carcinoembryonic antigen in colorectal cancer biomarker. Environ Res  2023,238(Pt 1),117113","journal-title":"Environ Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12951-022-01613-4","volume":"20","author":"Deng S.","year":"2022","unstructured":"Deng S.; Gu J.; Jiang Z.; Cao Y.; Mao F.; Xue Y.; Wang J.; Dai K.; Qin L.; Liu K.; Wu K.; He Q.; Cai K.; Application of nanotechnology in the early diagnosis and comprehensive treatment of gastrointestinal cancer. J Nanobiotechnology  2022,20(1),415","journal-title":"J Nanobiotechnology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1039\/D0CS00718H","volume":"50","author":"Xiong Y.","year":"2021","unstructured":"Xiong Y.; Xiao C.; Li Z.; Yang X.; Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev  2021,50(10),6013-6041","journal-title":"Chem Soc Rev"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"173198","DOI":"10.1016\/j.ejphar.2020.173198","volume":"880","author":"Xu Y.","year":"2020","unstructured":"Xu Y.; Qin Z.; Ma J.; Cao W.; Zhang P.; Recent progress in nanotechnology based ferroptotic therapies for clinical applications. Eur J Pharmacol  2020,880,173198","journal-title":"Eur J Pharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.7150\/thno.32867","volume":"9","author":"Zhu T.","year":"2019","unstructured":"Zhu T.; Shi L.; Yu C.; Dong Y.; Qiu F.; Shen L.; Qian Q.; Zhou G.; Zhu X.; Ferroptosis promotes photodynamic therapy: Supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment. Theranostics  2019,9(11),3293-3307","journal-title":"Theranostics"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"Su L.J.","year":"2019","unstructured":"Su L.J.; Zhang J.H.; Gomez H.; Murugan R.; Hong X.; Xu D.; Jiang F.; Peng Z.Y.; Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev  2019,2019,1-13","journal-title":"Oxid Med Cell Longev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"119958","DOI":"10.1016\/j.lfs.2021.119958","volume":"285","author":"Valashedi M.R.","year":"2021","unstructured":"Valashedi M.R.; Najafi-Ghalehlou N.; Nikoo A.; Bamshad C.; Tomita K.; Kuwahara Y.; Sato T.; Roushandeh A.M.; Roudkenar M.H.; Cashing in on ferroptosis against tumor cells: Usher in the next chapter. Life Sci  2021,285,119958","journal-title":"Life Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"Zorov D.B.","year":"2014","unstructured":"Zorov D.B.; Juhaszova M.; Sollott S.J.; Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev  2014,94(3),909-950","journal-title":"Physiol Rev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.biocel.2007.03.010","volume":"40","author":"Breuer W.","year":"2008","unstructured":"Breuer W.; Shvartsman M.; Cabantchik Z.I.; Intracellular labile iron. Int J Biochem Cell Biol  2008,40(3),350-354","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"Hassannia B.","year":"2019","unstructured":"Hassannia B.; Vandenabeele P.; Vanden B.T.; Targeting ferroptosis to iron out cancer. Cancer Cell  2019,35(6),830-849","journal-title":"Cancer Cell"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"Kagan V.E.","year":"2017","unstructured":"Kagan V.E.; Mao G.; Qu F.; Angeli J.P.F.; Doll S.; Croix C.S.; Dar H.H.; Liu B.; Tyurin V.A.; Ritov V.B.; Kapralov A.A.; Amoscato A.A.; Jiang J.; Anthonymuthu T.; Mohammadyani D.; Yang Q.; Proneth B.; Klein-Seetharaman J.; Watkins S.; Bahar I.; Greenberger J.; Mallampalli R.K.; Stockwell B.R.; Tyurina Y.Y.; Conrad M.; Bay\u0131r H.; Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol  2017,13(1),81-90","journal-title":"Nat Chem Biol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"Tsoi J.","year":"2018","unstructured":"Tsoi J.; Robert L.; Paraiso K.; Galvan C.; Sheu K.M.; Lay J.; Wong D.J.L.; Atefi M.; Shirazi R.; Wang X.; Braas D.; Grasso C.S.; Palaskas N.; Ribas A.; Graeber T.G.; Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell  2018,33(5),890-904.e5","journal-title":"Cancer Cell"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"Conrad M.","year":"2019","unstructured":"Conrad M.; Pratt D.A.; The chemical basis of ferroptosis. Nat Chem Biol  2019,15(12),1137-1147","journal-title":"Nat Chem Biol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1194\/jlr.M013292","volume":"52","author":"Golej D.L.","year":"2011","unstructured":"Golej D.L.; Askari B.; Kramer F.; Barnhart S.; Vivekanandan-Giri A.; Pennathur S.; Bornfeldt K.E.; Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells. J Lipid Res  2011,52(4),782-793","journal-title":"J Lipid Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"Yan B.","year":"2021","unstructured":"Yan B.; Ai Y.; Sun Q.; Ma Y.; Cao Y.; Wang J.; Zhang Z.; Wang X.; Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell  2021,81(2),355-369.e10","journal-title":"Mol Cell"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Zou Y.","year":"2020","unstructured":"Zou Y.; Li H.; Graham E.T.; Deik A.A.; Eaton J.K.; Wang W.; Sandoval-Gomez G.; Clish C.B.; Doench J.G.; Schreiber S.L.; Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol  2020,16(3),302-309","journal-title":"Nat Chem Biol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"Bersuker K.","year":"2019","unstructured":"Bersuker K.; Hendricks J.M.; Li Z.; Magtanong L.; Ford B.; Tang P.H.; Roberts M.A.; Tong B.; Maimone T.J.; Zoncu R.; Bassik M.C.; Nomura D.K.; Dixon S.J.; Olzmann J.A.; The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature  2019,575(7784),688-692","journal-title":"Nature"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"Kraft V.A.N.","year":"2020","unstructured":"Kraft V.A.N.; Bezjian C.T.; Pfeiffer S.; Ringelstetter L.; M\u00fcller C.; Zandkarimi F.; Merl-Pham J.; Bao X.; Anastasov N.; K\u00f6ssl J.; Brandner S.; Daniels J.D.; Schmitt-Kopplin P.; Hauck S.M.; Stockwell B.R.; Hadian K.; Schick J.A.; GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci  2020,6(1),41-53","journal-title":"ACS Cent Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"Mao C.","year":"2021","unstructured":"Mao C.; Liu X.; Zhang Y.; Lei G.; Yan Y.; Lee H.; Koppula P.; Wu S.; Zhuang L.; Fang B.; Poyurovsky M.V.; Olszewski K.; Gan B.; DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature  2021,593(7860),586-590","journal-title":"Nature"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"Stockwell B.R.","year":"2017","unstructured":"Stockwell B.R.; Friedmann Angeli J.P.; Bayir H.; Bush A.I.; Conrad M.; Dixon S.J.; Fulda S.; Gasc\u00f3n S.; Hatzios S.K.; Kagan V.E.; Noel K.; Jiang X.; Linkermann A.; Murphy M.E.; Overholtzer M.; Oyagi A.; Pagnussat G.C.; Park J.; Ran Q.; Rosenfeld C.S.; Salnikow K.; Tang D.; Torti F.M.; Torti S.V.; Toyokuni S.; Woerpel K.A.; Zhang D.D.; Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell  2017,171(2),273-285","journal-title":"Cell"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1904197","DOI":"10.1002\/adma.201904197","volume":"31","author":"Liang C.","year":"2019","unstructured":"Liang C.; Zhang X.; Yang M.; Dong X.; Recent progress in ferroptosis inducers for cancer therapy. Adv Mater  2019,31(51),1904197","journal-title":"Adv Mater"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"Guo J.","year":"2018","unstructured":"Guo J.; Xu B.; Han Q.; Zhou H.; Xia Y.; Gong C.; Dai X.; Li Z.; Wu G.; Ferroptosis: A novel anti-tumor action for cisplatin. Cancer Res Treat  2018,50(2),445-460","journal-title":"Cancer Res Treat"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"Ma S.","year":"2016","unstructured":"Ma S.; Henson E.S.; Chen Y.; Gibson S.B.; Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis  2016,7(7),e2307","journal-title":"Cell Death Dis"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","volume":"8","author":"Sato M.","year":"2018","unstructured":"Sato M.; Kusumi R.; Hamashima S.; Kobayashi S.; Sasaki S.; Komiyama Y.; Izumikawa T.; Conrad M.; Bannai S.; Sato H.; The ferroptosis inducer erastin irreversibly inhibits system xc\u2212 and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells. Sci Rep  2018,8(1),968","journal-title":"Sci Rep"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"Viswanathan V.S.","year":"2017","unstructured":"Viswanathan V.S.; Ryan M.J.; Dhruv H.D.; Gill S.; Eichhoff O.M.; Seashore-Ludlow B.; Kaffenberger S.D.; Eaton J.K.; Shimada K.; Aguirre A.J.; Viswanathan S.R.; Chattopadhyay S.; Tamayo P.; Yang W.S.; Rees M.G.; Chen S.; Boskovic Z.V.; Javaid S.; Huang C.; Wu X.; Tseng Y.Y.; Roider E.M.; Gao D.; Cleary J.M.; Wolpin B.M.; Mesirov J.P.; Haber D.A.; Engelman J.A.; Boehm J.S.; Kotz J.D.; Hon C.S.; Chen Y.; Hahn W.C.; Levesque M.P.; Doench J.G.; Berens M.E.; Shamji A.F.; Clemons P.A.; Stockwell B.R.; Schreiber S.L.; Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature  2017,547(7664),453-457","journal-title":"Nature"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"Chen X.","year":"2021","unstructured":"Chen X.; Kang R.; Kroemer G.; Tang D.; Broadening horizons: The role of ferroptosis in cancer. Nat Rev Clin Oncol  2021,18(5),280-296","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"Hangauer M.J.","year":"2017","unstructured":"Hangauer M.J.; Viswanathan V.S.; Ryan M.J.; Bole D.; Eaton J.K.; Matov A.; Galeas J.; Dhruv H.D.; Berens M.E.; Schreiber S.L.; McCormick F.; McManus M.T.; Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature  2017,551(7679),247-250","journal-title":"Nature"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"Lei G.","year":"2020","unstructured":"Lei G.; Zhang Y.; Koppula P.; Liu X.; Zhang J.; Lin S.H.; Ajani J.A.; Xiao Q.; Liao Z.; Wang H.; Gan B.; The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res  2020,30(2),146-162","journal-title":"Cell Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"101993","DOI":"10.1016\/j.redox.2021.101993","volume":"43","author":"Bai X.","year":"2021","unstructured":"Bai X.; Ni J.; Beretov J.; Wasinger V.C.; Wang S.; Zhu Y.; Graham P.; Li Y.; Activation of the eIF2\u03b1\/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis. Redox Biol  2021,43,101993","journal-title":"Redox Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","volume":"21","author":"Bukowski K.","year":"2020","unstructured":"Bukowski K.; Kciuk M.; Kontek R.; Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci  2020,21(9),3233","journal-title":"Int J Mol Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.7150\/thno.42523","volume":"10","author":"Ravindran Menon D.","year":"2020","unstructured":"Ravindran Menon D.; Hammerlindl H.; Torrano J.; Schaider H.; Fujita M.; Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics  2020,10(14),6261-6277","journal-title":"Theranostics"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"605777","DOI":"10.3389\/fonc.2020.605777","volume":"10","author":"Zhang M.X.","year":"2021","unstructured":"Zhang M.X.; Wang L.; Zeng L.; Tu Z.W.; LCN2 is a potential biomarker for radioresistance and recurrence in nasopharyngeal carcinoma. Front Oncol  2021,10,605777","journal-title":"Front Oncol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2182992","DOI":"10.1080\/2162402X.2023.2182992","volume":"12","author":"Demuynck R.","year":"2023","unstructured":"Demuynck R.; Efimova I.; Catanzaro E.; Krysko D.V.; Ferroptosis: Friend or foe in cancer immunotherapy? OncoImmunology  2023,12(1),2182992","journal-title":"OncoImmunology"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41392-023-01357-z","volume":"8","author":"Du S.","year":"2023","unstructured":"Du S.; Zeng F.; Deng G.; Tumor neutrophils ferroptosis: A targetable immunosuppressive mechanism for cancer immunotherapy. Signal Transduct Target Ther  2023,8(1),77","journal-title":"Signal Transduct Target Ther"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"Chen D.S.","year":"2017","unstructured":"Chen D.S.; Mellman I.; Elements of cancer immunity and the cancer\u2013immune set point. Nature  2017,541(7637),321-330","journal-title":"Nature"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"Sharma P.","year":"2015","unstructured":"Sharma P.; Allison J.P.; The future of immune checkpoint therapy. Science  2015,348(6230),56-61","journal-title":"Science"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","volume":"170","author":"Wei S.C.","year":"2017","unstructured":"Wei S.C.; Levine J.H.; Cogdill A.P.; Zhao Y.; Anang N.A.A.S.; Andrews M.C.; Sharma P.; Wang J.; Wargo J.A.; Pe\u2019er D.; Allison J.P.; Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell  2017,170(6),1120-1133.e17","journal-title":"Cell"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"Morad G.","year":"2021","unstructured":"Morad G.; Helmink B.A.; Sharma P.; Wargo J.A.; Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell  2021,184(21),5309-5337","journal-title":"Cell"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jhep.2022.10.037","volume":"78","author":"Yuen V.W.H.","year":"2023","unstructured":"Yuen V.W.H.; Chiu D.K.C.; Law C.T.; Cheu J.W.S.; Chan C.Y.K.; Wong B.P.Y.; Goh C.C.; Zhang M.S.; Xue H.D.G.; Tse A.P.W.; Zhang Y.; Lau H.Y.H.; Lee D.; Au-Yeung R.K.H.; Wong C.M.; Wong C.C.L.; Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses. J Hepatol  2023,78(2),376-389","journal-title":"J Hepatol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","volume":"10","author":"Bonaventura P.","year":"2019","unstructured":"Bonaventura P.; Shekarian T.; Alcazer V.; Valladeau-Guilemond J.; Valsesia-Wittmann S.; Amigorena S.; Caux C.; Depil S.; Cold tumors: A therapeutic challenge for immunotherapy. Front Immunol  2019,10,168","journal-title":"Front Immunol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"Galon J.","year":"2019","unstructured":"Galon J.; Bruni D.; Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov  2019,18(3),197-218","journal-title":"Nat Rev Drug Discov"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","volume":"43","author":"Zhang J.","year":"2022","unstructured":"Zhang J.; Huang D.; Saw P.E.; Song E.; Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends Immunol  2022,43(7),523-545","journal-title":"Trends Immunol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1113882","DOI":"10.3389\/fimmu.2023.1113882","volume":"14","author":"Daei Sorkhabi A.","year":"2023","unstructured":"Daei Sorkhabi A.; Mohamed Khosroshahi L.; Sarkesh A.; Mardi A.; Aghebati-Maleki A.; Aghebati-Maleki L.; Baradaran B.; The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. Front Immunol  2023,14,1113882","journal-title":"Front Immunol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.7150\/ijbs.34213","volume":"15","author":"Ma S.","year":"2019","unstructured":"Ma S.; Li X.; Wang X.; Cheng L.; Li Z.; Zhang C.; Ye Z.; Qian Q.; Current progress in CAR-T cell therapy for solid tumors. Int J Biol Sci  2019,15(12),2548-2560","journal-title":"Int J Biol Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"Szak\u00e1cs G.","year":"2006","unstructured":"Szak\u00e1cs G.; Paterson J.K.; Ludwig J.A.; Booth-Genthe C.; Gottesman M.M.; Targeting multidrug resistance in cancer. Nat Rev Drug Discov  2006,5(3),219-234","journal-title":"Nat Rev Drug Discov"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1039\/D2TB02161G","volume":"11","author":"Yin W.","year":"2023","unstructured":"Yin W.; Chang J.; Sun J.; Zhang T.; Zhao Y.; Li Y.; Dong H.; Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy. J Mater Chem B Mater Biol Med  2023,11(6),1171-1190","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1021\/acsnano.1c00380","volume":"15","author":"Xie S.","year":"2021","unstructured":"Xie S.; Sun W.; Zhang C.; Dong B.; Yang J.; Hou M.; Xiong L.; Cai B.; Liu X.; Xue W.; Metabolic control by heat stress determining cell fate to ferroptosis for effective cancer therapy. ACS Nano  2021,15(4),7179-7194","journal-title":"ACS Nano"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"29655","DOI":"10.1021\/acsami.9b10954","volume":"11","author":"An Y.","year":"2019","unstructured":"An Y.; Zhu J.; Liu F.; Deng J.; Meng X.; Liu G.; Wu H.; Fan A.; Wang Z.; Zhao Y.; Boosting the ferroptotic antitumor efficacy via site-specific amplification of tailored lipid peroxidation. ACS Appl Mater Interfaces  2019,11(33),29655-29666","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/acs.nanolett.6b04269","volume":"17","author":"Ma P.","year":"2017","unstructured":"Ma P.; Xiao H.; Yu C.; Liu J.; Cheng Z.; Song H.; Zhang X.; Li C.; Wang J.; Gu Z.; Lin J.; Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species. Nano Lett  2017,17(2),928-937","journal-title":"Nano Lett"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.biomaterials.2019.01.026","volume":"197","author":"Yao X.","year":"2019","unstructured":"Yao X.; Yang P.; Jin Z.; Jiang Q.; Guo R.; Xie R.; He Q.; Yang W.; Multifunctional nanoplatform for photoacoustic imaging-guided combined therapy enhanced by CO induced ferroptosis. Biomaterials  2019,197,268-283","journal-title":"Biomaterials"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1570159X14666160825160421","volume":"15","author":"Isola A.L.","year":"2017","unstructured":"Isola A.L.; Chen S.; Exosomes: The messengers of health and disease. Curr Neuropharmacol  2017,15(1),157-165","journal-title":"Curr Neuropharmacol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"Kalluri R.","year":"2020","unstructured":"Kalluri R.; LeBleu V.S.; The biology, function, and biomedical applications of exosomes. Science  2020,367(6478),eaau6977","journal-title":"Science"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","volume":"219","author":"Batrakova E.V.","year":"2015","unstructured":"Batrakova E.V.; Kim M.S.; Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release  2015,219,396-405","journal-title":"J Control Release"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Liang Y.","year":"2021","unstructured":"Liang Y.; Duan L.; Lu J.; Xia J.; Engineering exosomes for targeted drug delivery. Theranostics  2021,11(7),3183-3195","journal-title":"Theranostics"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.7150\/thno.32363","volume":"9","author":"Qiu X.","year":"2019","unstructured":"Qiu X.; Li Z.; Han X.; Zhen L.; Luo C.; Liu M.; Yu K.; Ren Y.; Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis. Theranostics  2019,9(9),2618-2636","journal-title":"Theranostics"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"8185","DOI":"10.7150\/thno.59121","volume":"11","author":"Du J.","year":"2021","unstructured":"Du J.; Wan Z.; Wang C.; Lu F.; Wei M.; Wang D.; Hao Q.; Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy. Theranostics  2021,11(17),8185-8196","journal-title":"Theranostics"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"e20210518","DOI":"10.1084\/jem.20210518","volume":"218","author":"Chen X.","year":"2021","unstructured":"Chen X.; Kang R.; Kroemer G.; Tang D.; Ferroptosis in infection, inflammation, and immunity. J Exp Med  2021,218(6),e20210518","journal-title":"J Exp Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"Fang X.","year":"2023","unstructured":"Fang X.; Ardehali H.; Min J.; Wang F.; The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol  2023,20(1),7-23","journal-title":"Nat Rev Cardiol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"Stockwell B.R.","year":"2022","unstructured":"Stockwell B.R.; Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell  2022,185(14),2401-2421","journal-title":"Cell"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1016\/j.cell.2023.06.002","volume":"186","author":"Ma L.","year":"2023","unstructured":"Ma L.; Hostetler A.; Morgan D.M.; Maiorino L.; Sulkaj I.; Whittaker C.A.; Neeser A.; Pires I.S.; Yousefpour P.; Gregory J.; Qureshi K.; Dye J.; Abraham W.; Suh H.; Li N.; Love J.C.; Irvine D.J.; Vaccine-boosted C.A.R.; Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity. Cell  2023,186(15),3148-3165.e20","journal-title":"Cell"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.7150\/ijbs.83342","volume":"19","author":"Feng Y.","year":"2023","unstructured":"Feng Y.; Dai Y.; APOL3-LDHA axis related immunity activation and cancer ferroptosis induction. Int J Biol Sci  2023,19(5),1401-1402","journal-title":"Int J Biol Sci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","volume":"16","author":"Dai E.","year":"2020","unstructured":"Dai E.; Han L.; Liu J.; Xie Y.; Kroemer G.; Klionsky D.J.; Zeh H.J.; Kang R.; Wang J.; Tang D.; Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy  2020,16(11),2069-2083","journal-title":"Autophagy"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010276664231228124157","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226285\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010276664231228124157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:41:52Z","timestamp":1727084512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226285\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":114,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010276664231228124157","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}